U Schuler|G Ehninger - JoVE Visualize

Showing results (21-30 of 328) with videos related to

Pageof 33

Sort By:

Reviews in Immunogenetics|October 4, 2002

Approaches to managing volunteer marrow donor registry HLA data. Algorithms for directing donor center-initiated HLA-DR typing of selected donorsU Schuler, C Rutt, D Baier, et al.

Deutsche Medizinische Wochenschrift (1946)|July 31, 1987

[Anterior wall infarct in an 18-year-old patient with Hodgkin's disease. Possible relation between mediastinal irradiation, accelerated arteriosclerosis and vincristine chemotherapy]W Voelker, U Schuler, G Ehninger, et al.

Cancer Research|November 15, 1987

Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patientsG Ehninger, T Klingebiel, I Kumbier, et al.

Bone Marrow Transplantation|February 22, 2005

Pelvic magnetic resonance imaging after bone marrow harvest--a retrospective study in 50 unrelated marrow donorsF Kroschinsky, T Kittner, S Mauersberger, et al.

Blood|June 1, 1995

Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine modelG Ehninger, U Schuler, U Renner, et al.

Cancer Genetics and Cytogenetics|August 1, 1996

Complex cytogenetic and immunophenotypic aberrations in a patient with Sezary syndromeB Mohr, T Illmer, U Oelschlägel, et al.

Bone Marrow Transplantation|August 26, 1998

Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donorsR Ordemann, K Hölig, K Wagner, et al.

Transplantation|March 10, 1999

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantationM Bornhäuser, U Schuler, G Pörksen, et al.

Leukemia|June 1, 1992

Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposideG Ehninger, B Proksch, T Wanner, et al.

Bone Marrow Transplantation|November 1, 1994

Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?U Schuler, S Schroer, A Kühnle, et al.

Pageof 33

Showing results (21-30 of 328) with videos related to

Sort By:

Pageof 33

Reviews in Immunogenetics|October 4, 2002

Approaches to managing volunteer marrow donor registry HLA data. Algorithms for directing donor center-initiated HLA-DR typing of selected donorsU Schuler, C Rutt, D Baier, et al.

Deutsche Medizinische Wochenschrift (1946)|July 31, 1987

[Anterior wall infarct in an 18-year-old patient with Hodgkin's disease. Possible relation between mediastinal irradiation, accelerated arteriosclerosis and vincristine chemotherapy]W Voelker, U Schuler, G Ehninger, et al.

Cancer Research|November 15, 1987

Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patientsG Ehninger, T Klingebiel, I Kumbier, et al.

Bone Marrow Transplantation|February 22, 2005

Pelvic magnetic resonance imaging after bone marrow harvest--a retrospective study in 50 unrelated marrow donorsF Kroschinsky, T Kittner, S Mauersberger, et al.

Blood|June 1, 1995

Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine modelG Ehninger, U Schuler, U Renner, et al.

Cancer Genetics and Cytogenetics|August 1, 1996

Complex cytogenetic and immunophenotypic aberrations in a patient with Sezary syndromeB Mohr, T Illmer, U Oelschlägel, et al.

Bone Marrow Transplantation|August 26, 1998

Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donorsR Ordemann, K Hölig, K Wagner, et al.

Transplantation|March 10, 1999

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantationM Bornhäuser, U Schuler, G Pörksen, et al.

Leukemia|June 1, 1992

Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposideG Ehninger, B Proksch, T Wanner, et al.

Bone Marrow Transplantation|November 1, 1994

Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?U Schuler, S Schroer, A Kühnle, et al.

Pageof 33